New study explores how immigration affects prostate cancer care

NCT ID NCT06472817

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study interviews 80 immigrant men from Sub-Saharan Africa and the Caribbean who have been diagnosed with prostate cancer. Researchers want to understand how social factors like where they come from affect their health decisions, treatment, and survival. The goal is to identify patterns that could reduce health disparities in prostate cancer care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help doctors and health systems better support immigrant men with prostate cancer by understanding their unique social and cultural needs.
What could go wrong: This is an early-stage, non-interventional study with only 80 participants, so findings may not apply to all immigrant groups. It aims to gather insights, not test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CARCINOMA

Contacts and locations

Locations

Georgia State University

Atlanta, Georgia, 30302-3965, United States
Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.